Glucose Health, Inc. cash flow statement GLUC

In Q3 of fiscal 2017, the quarter ended Sep 30, 2017, Glucose Health, Inc. used $1,677 of cash from operations, down 102.7% from the same quarter a year earlier.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Sep 30, 2017
Q3 FY2017
Sep 30, 2017
Q2 FY2017
Jun 30, 2017
Q1 FY2017
Mar 31, 2017
Q4 FY2016
Dec 31, 2016
Q3 FY2016
Sep 30, 2016
Q2 FY2016
Jun 30, 2016
Q1 FY2016
Mar 31, 2016
Q4 FY2015
Dec 31, 2015
Operating
Stock-based compensation
—
0
—
—
—
—
—
—
—
Operating cash flow
-0
+61.8%
-0
-102.7%
-0
+98.6%
-0
+76.3%
-0
+63.8%
0
+177.4%
-0
-215.7%
-0
+29.7%
-0
+74.0%
Investing
Investing cash flow
—
—
—
—
0
—
—
—
—
Financing
Financing cash flow
0
-83.3%
0
+100.0%
-0
-131.2%
—
0
-100.0%
-0
-177.9%
0
+398.9%
0
-28.0%
0
-93.7%
Ratios
Cash conversion
—
-0.09x
-0.01x
—
—
—
—
—
—
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
GLUC (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bentonville, AR
SEC filer status
Smaller reporting company
SEC CIK
1420108
Former names
Bio-Solutions Corp. (until Dec 16, 2014)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.